Drawing for FE3 MEDICAL, INC.

USPTO serial 76706610

FE3 MEDICAL, INC.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PINO, BRIAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FE3 MEDICAL, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William L Paradice III

William L Paradice III Mahamedi Paradice Kreisman LLP1901 S. Bascom AvenueSte. 600Campbell, CA 95008

Goods and services

ClassDescriptionStatusFirst use
005Transdermal drug delivery patches containing iron or ferric ions for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; iontophoretic transdermal drug delivery patches containing iron or ferric ions for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; transdermal drug compounds containing iron or ferric ions, namely, compounds for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disordersACTIVE—
009Iontophoretic transdermal power supplies, namely, power supplies for delivery of transdermal drug compounds from iontophoretic transdermal drug delivery patches for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disordersACTIVE—
010Transdermal drug delivery patches sold without medication; iontophoretic transdermal drug delivery patches sold without medication; mixing bottles for mixing transdermal drug solutions, sold empty; iontophoretic transdermal electronic control systems, namely, systems for controlling the delivery of transdermal drug compounds from iontophoretic transdermal drug delivery patches for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 18, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 18, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 23, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 22, 2014EX2GSOU EXTENSION 2 GRANTED—
Jan 21, 2014NREVNOTICE OF REVIVAL - E-MAILED—
Jan 21, 2014TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jan 21, 2014PETGPETITION TO REVIVE-GRANTED—
Jan 21, 2014PROATEAS PETITION TO REVIVE RECEIVED—
Jan 15, 2014EXT2SOU EXTENSION 2 FILED—
Dec 12, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 11, 2013EX1GSOU EXTENSION 1 GRANTED—
Dec 9, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 17, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 17, 2013NREVNOTICE OF REVIVAL - E-MAILED—
Oct 17, 2013TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 17, 2013PETGPETITION TO REVIVE-GRANTED—
Oct 17, 2013PROATEAS PETITION TO REVIVE RECEIVED—
Aug 19, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 19, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 15, 2013EXT1SOU EXTENSION 1 FILED—
Jan 15, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 20, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 20, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 31, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 17, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 17, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Oct 17, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 17, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 17, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 15, 2012ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 28, 2012PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 14, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 14, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 4, 2012ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 26, 2012PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 10, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 8, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Aug 8, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 8, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 8, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 26, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 26, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2012MAILPAPER RECEIVED—
Jul 11, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 12, 2012CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 12, 2012CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2012DMCCDATA MODIFICATION COMPLETED—
Dec 22, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 22, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2011ALIEASSIGNED TO LIE—
Dec 13, 2011MAILPAPER RECEIVED—
Jun 8, 2011CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2011DOCKASSIGNED TO EXAMINER—
Mar 5, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 1, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance